📣 Try out the NEW Gateway to Research and let us know what you think.

We're looking for users to test the new service during August and September and share their feedback. Express your interest by completing this short form.

Intranasal administration of PTH(1-34) for the treatment of osteoporosis - equivalence to subcutaneous injection at the neck of femur in the Food and Drug Administration (FDA) mandated preclinical model (Oral Presentation - Pearson). (2015)

First Author: Williams AJ
Attributed to:  PTH nasal delivery for the treatment of osteoporosis - TSB NINTTO funded by EPSRC

Abstract

No abstract provided

Bibliographic Information

Publication URI: http://abstracts.ects-ibms2015.org/ectsibms/0001/ectsibms0001p341.htm

Type: Conference/Paper/Proceeding/Abstract